Alpha interferon administration to infants with congenital rubella
- PMID: 6176183
- PMCID: PMC181869
- DOI: 10.1128/AAC.21.2.259
Alpha interferon administration to infants with congenital rubella
Abstract
Three infants with congenital rubella syndrome were given human leukocyte (alpha) interferon at doses of 2 x 10(5) to 7 X 10(5) U/kg per day for 10 days. A transient decrease in pharyngeal virus excretion was observed with treatment. No significant side effects were associated with the administration of human leukocyte interferon to these infants.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical